Page 14 - Dementia-Care-Specialist-Toolkit
P. 14

Alzheimer’s Disease and Its Impact







        Alzheimer’s Disease is the Most Common Form of Dementia and it Disproportionately Impacts Many Californians.
        Dementia is a general term for memory loss and other impairments serious enough to interfere with daily life. Alzheimer’s
        accounts for 60 to 80 percent of dementia cases and currently impacts an estimated 610,000 Californians, a number
        projected to grow to 840,000 by 2025. Alzheimer’s is the 5th leading cause of death in California and the only condition in the
        top 10 without a known cause, cure, or prevention.

        More women than men have Alzheimer’s disease and other dementias such as vascular dementia and dementia with Lewy
        bodies, among others. Almost two-thirds of Americans with Alzheimer’s are women, as are the majority of family caregivers.
        Older African Americans and Hispanics are more likely than older whites to have Alzheimer’s disease and other dementias
        with African Americans at twice the prevalence rate and Hispanics one and one-half times the rate.

        This 2017 Update Reflects New Evidence, Improved Practice and Changes in Law — This is the 4th edition of the
        California Alzheimer’s Clinical Care Guideline, first published in 1998 and revised in 2002 and 2008. The 2017 update
        specified in statute (SB 613, Chapter 577, 201 ) addresses changes in scientific evidence, clinical practice, and state and
        federal law. Changes include:

        NEW GOVERNMENT POLICIES
                                                                    New Evidence About Antipsychotic Medications
        Medicare Reimbursement — The Centers for Medicare           and FDA Black Box Warning Labels —In April 2005,
        & Medicaid Services (CMS) now reimburses physicians for     the U.S. Food and Drug Administration (FDA) notified
        annual wellness visits every 12 months and includes         health care professionals that both conventional and
        payment for a Health Risk Assessment, including             atypical antipsychotics are associated with an
        reimbursement for a cognitive screen. Medicare will pay for   increased risk of mortality in elderly patients treated for
        cognitive and functional assessments and care planning for   dementia-related psychosis. The FDA notified health
        patients with Alzheimer’s disease and other cognitive       care professionals that patients with dementia-related
        impairments.                                                psychosis treated with atypical antipsychotic drugs are
                                                                    at an increased risk of death. Since issuing that
        Adoption of Physician Order for Life Sustaining             notification, the FDA has reviewed additional information
        Treatment (POLST) — The POLST form gives patients           that indicates the risk also is associated with
        more control over their end-of-life care, including medical  conventional antipsychotics.
        treatment, extraordinary measures (such as a ventilator or
        feeding tube) and Cardiopulmonary resuscitation. POLST      Gaps in Disclosure and Documentation — Scientists
        can prevent unwanted treatments, reduce patient and family  who studied patient surveys and Medicare claims data
        suffering, and ensure a patient’s wishes are honored.       discovered only 45 percent of those billed for
                                                                    Alzheimer’s-related care were told by their doctors of
                                                                    their disease. Overlooking or avoiding diagnosis
        Social Security Grants Compassionate Allowance Benefit
        for Early-Onset Individuals — Individuals under age 65      impedes care and denies access to needed services.
                                                                    In an era of electronic health records, documenting the
        diagnosed with Alzheimer’s disease are eligible for the Social
        Security Administration’s compassionate allowance benefit   diagnosis is critically important in order to deliver
        with minimal objective medical information provided by a    person-centered care.
        physician.
                                                                    Lifestyle Modifications — Some risk factors for
        Healthy Brain Initiative — The Centers for Disease Control  dementia, such as age and genetics, cannot be
        and Prevention has mapped out a strategy for state and      changed, but the brain can be protected by some of
        national partnerships through The Healthy Brain Initiative  the same strategies that guard against cardiovascular
        emphasizing proven public health strategies such            risk, including smoking cessation; keeping blood
        as monitoring and evaluation, education and training, policy  pressure, cholesterol and blood sugar within
        development, and workforce competencies.                    recommended limits; and, maintaining a healthy
                                                                    weight. Regular physical exercise may help lower
        EMERGING PRACTICE TRENDS                                    dementia risk. Diet may impact brain health through its
                                                                    effect on heart health. Evidence suggests heart-
        Emphasis on Early Detection, Early Diagnosis and Mild       healthy eating patterns, such as the Mediterranean
        Cognitive Impairment — Mild cognitive impairment can cause   diet, which emphasizes eating foods like fish, fruits,
        serious cognitive changes noticed by those individuals who  vegetables, beans, high-fiber breads and whole grains,
        experience changes or by other people, but not severe enough  nuts, and olive oil may help protect the brain.
        to interfere with daily life or independent function. As with other
        chronic diseases, public health experts are focusing on
        possible early interventions to delay the onset and slow the
        progression of Alzheimer’s disease.


                                                                                                                     14
   9   10   11   12   13   14   15   16   17   18   19